| Christopher Ko, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Christopher Ko |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 9 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497142301 | NPI | - | NPPES |
| CK2322267556 | Other | CA | USC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 4301503832 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
Mobile technology has changed the way we live our lives. Going beyond business productivity, mobile devices have become the preferred way for consumers to manage everything from their finances to personal health, with the latter being the fastest growing corner of the category.
Current view is that cancer development is initiated from cells that acquire initial DNA mutations. These in turn provoke additional defects, and ultimately the affected cells begin to proliferate in an uncontrolled manner to develop primary tumors.
Developments in hospital news also include an analysis of Maryland's success with rate regulation, the economic power of health care jobs in San Francisco and reports that a Mass. hospital system is launching a health plan.
The world's top scientists and clinicians in the human genetics field will gather in Washington, D.C., to present their latest research findings at the 60th Annual Meeting of the American Society of Human Genetics, from Tuesday, November 2, through Saturday, November 6, 2010, at the Walter E. Washington Convention Center in D.C.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
› Verified 7 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Mobile technology has changed the way we live our lives. Going beyond business productivity, mobile devices have become the preferred way for consumers to manage everything from their finances to personal health, with the latter being the fastest growing corner of the category.
Current view is that cancer development is initiated from cells that acquire initial DNA mutations. These in turn provoke additional defects, and ultimately the affected cells begin to proliferate in an uncontrolled manner to develop primary tumors.
Developments in hospital news also include an analysis of Maryland's success with rate regulation, the economic power of health care jobs in San Francisco and reports that a Mass. hospital system is launching a health plan.
The world's top scientists and clinicians in the human genetics field will gather in Washington, D.C., to present their latest research findings at the 60th Annual Meeting of the American Society of Human Genetics, from Tuesday, November 2, through Saturday, November 6, 2010, at the Walter E. Washington Convention Center in D.C.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Ko, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Christopher Ko, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
Mobile technology has changed the way we live our lives. Going beyond business productivity, mobile devices have become the preferred way for consumers to manage everything from their finances to personal health, with the latter being the fastest growing corner of the category.
Current view is that cancer development is initiated from cells that acquire initial DNA mutations. These in turn provoke additional defects, and ultimately the affected cells begin to proliferate in an uncontrolled manner to develop primary tumors.
Developments in hospital news also include an analysis of Maryland's success with rate regulation, the economic power of health care jobs in San Francisco and reports that a Mass. hospital system is launching a health plan.
The world's top scientists and clinicians in the human genetics field will gather in Washington, D.C., to present their latest research findings at the 60th Annual Meeting of the American Society of Human Genetics, from Tuesday, November 2, through Saturday, November 6, 2010, at the Walter E. Washington Convention Center in D.C.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
› Verified 7 days ago
Nabil Alkhoury Fallouh, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 3rd Floor Taubman Ctr Recp B, Ann Arbor, MI 48109 Phone: 734-936-5582 | |
Sameer Dev Saini, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. David Alexander Stewart, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, 12th Floor C.s. Mott Children's Hospital Room 525, Ann Arbor, MI 48109 Phone: 734-763-5302 Fax: 734-647-5624 | |
Dr. Aiman M Mahmood, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Med Inn C728, Ann Arbor, MI 48109 Phone: 734-998-0891 | |
Anastasia Irene Wasylyshyn, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Katherine Saber Salisbury, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4260 Plymouth Rd, Ann Arbor, MI 48109 Phone: 734-764-6831 | |
Anne Lewis Carlton, Gastroenterology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-647-5900 |